UBS lowered the firm’s price target on Procter & Gamble to $189 from $196 and keeps a Buy rating on the shares. Sentiment around Consumer ...
JPMorgan analyst Andrea Teixeira lowered the firm’s price target on Procter & Gamble to $181 from $186 and keeps an Overweight rating on ...
James reaffirmed a positive outlook on Procter & Gamble shares (NYSE:NYSE:PG), maintaining both an Outperform rating and a ...
In its upcoming report, Procter & Gamble (PG) is predicted by Wall Street analysts to post quarterly earnings of $1.87 per share, reflecting an increase of 1.6% compared to the same period last year.
Procter & Gamble Hygiene & Healthcare Ltd. key Products/Revenue Segments include Hygiene Products, Creams & Ointments, Cough Drops, Tablets for the year ending 30-Jun-2024.For the quarter ended ...